Yongxin Ren
- Hepatology top 10%
- Liver physiology and pathology 9
- Hepatocellular Carcinoma Treatment and Prognosis 4
-
- Chronic Lymphocytic Leukemia Research 3
-
- Cancer Mechanisms and Therapy 3
-
- Natural Compounds in Disease Treatment 3
-
- Lung Cancer Treatments and Mutations 4
-
- PI3K/AKT/mTOR signaling in cancer 3
-
- Pancreatic and Hepatic Oncology Research 2
- Cited by
- HepatologyCancer ResearchGenetics
- Journals
- Journal of Clinical Investigation (2 papers)Journal of Clinical Oncology (2 papers)Blood (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Yongxin Ren
32 papers receiving 697 citations
Peers
Comparison fields: 5 of 89
- Hepatology 85
- Cancer Research 120
- Genetics 71
- Pathology and Forensic Medicine 107
- Complementary and alternative medicine 46
Countries citing papers authored by Yongxin Ren
This map shows the geographic impact of Yongxin Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongxin Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongxin Ren more than expected).
Fields of papers citing papers by Yongxin Ren
This network shows the impact of papers produced by Yongxin Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongxin Ren. The network helps show where Yongxin Ren may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yongxin Ren, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 4 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 46 | |
| 9 | 2021 | 42 | |
| 10 | 2019 | 15 | |
| 11 | 2019 | 16 | |
| 12 | 2017 | 6 | |
| 13 | 2017 | 145 | |
| 14 | 2013 | 98 | |
| 15 | 2013 | 2 | |
| 16 | 2007 | 30 | |
| 17 | 2007 | 16 | |
| 18 | 2006 | 12 | |
| 19 | 2006 | 33 | |
| 20 | 2006 | 14 |
About Yongxin Ren
Yongxin Ren is a scholar working on Hepatology, Hematology and Genetics, having authored 36 papers that have together received 703 indexed citations. Recurring topics across this work include Liver physiology and pathology (9 papers), Lung Cancer Treatments and Mutations (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Cancer Mechanisms and Therapy (3 papers), Natural Compounds in Disease Treatment (3 papers) and Pancreatic and Hepatic Oncology Research (2 papers). The work is most often cited by research in Hepatology (85 citations), Cancer Research (120 citations) and Genetics (71 citations). Yongxin Ren has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Weiguo Su, Weiguo Qing, Jianping Zuo, Guoyong Yin, Ru Zhou, Gong Yang, Xizhi Guo, Shiming Fan, Yinghua Li and Hanjun Li. Their work appears in journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.